Close Menu

NEW YORK – P23 Labs has received Emergency Use Authorization for its coronavirus PCR test from the US Food and Drug Administration.

The TaqPath SARS-CoV-2 test is authorized for use with oropharyngeal, nasopharyngeal, anterior nasal, and mid-turbinate nasal swabs, as well as nasopharyngeal wash, nasal aspirate specimens, and bronchoalveolar lavage samples. In addition, it can use saliva samples collected using OraSure Technologies' Omnigene Oral OM-505 saliva collection device.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.